BN Business News
Add your company to Business Communicator →

Business · 28/09/2018Updated: 10/17/2026 · 1 min read

FDA Withdraws Proposed Rules on Cattle-Derived Materials in Medical Products

The US Food and Drug Administration (FDA) has withdrawn two proposed rules related to the use of materials derived from cattle in medical products for human use and drugs for ruminant use, citing that the current regulatory requirements are not necessary to protect public health.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →